Connecticut 2012 Regular Session

Connecticut House Bill HB05012 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	General Assembly Raised Bill No. 5012
2	2	February Session, 2012 LCO No. 41
3	3	00041_______INS
4	4	Referred to Committee on Insurance and Real Estate
5	5	Introduced by:
6	6	(INS)
7	7
8	8	General Assembly
9	9
10	10	Raised Bill No. 5012
11	11
12	12	February Session, 2012
13	13
14	14	LCO No. 41
15	15
16	16	00041_______INS
17	17
18	18	Referred to Committee on Insurance and Real Estate
19	19
20	20	Introduced by:
21	21
22	22	(INS)
23	23
24	24	AN ACT CONCERNING THE GUIDELINES ESTABLISHED BY THE AMERICAN UROLOGICAL ASSOCIATION AND THE TREATMENT OF PROSTATE CANCER.
25	25
26	26	Be it enacted by the Senate and House of Representatives in General Assembly convened:
27	27
28	28	Section 1. Section 38a-492g of the 2012 supplement to the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2013):
29	29
30	30	Each individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state shall provide coverage for:
31	31
32	32	(1) Laboratory and diagnostic tests, including, but not limited to, prostate specific antigen (PSA) tests, to screen for prostate cancer for men who are symptomatic or whose biological father or brother has been diagnosed with prostate cancer, and for all men fifty years of age or older; and
33	33
34	34	(2) The treatment of prostate cancer, provided such treatment is medically necessary and in accordance with guidelines established by the National Comprehensive Cancer Network, the American Cancer Society, [or] the American Society of Clinical Oncology or the American Urological Association.
35	35
36	36	Sec. 2. Section 38a-518g of the 2012 supplement to the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2013):
37	37
38	38	Each group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state shall provide coverage for:
39	39
40	40	(1) Laboratory and diagnostic tests, including, but not limited to, prostate specific antigen (PSA) tests, to screen for prostate cancer for men who are symptomatic or whose biological father or brother has been diagnosed with prostate cancer, and for all men fifty years of age or older; and
41	41
42	42	(2) The treatment of prostate cancer, provided such treatment is medically necessary and in accordance with guidelines established by the National Comprehensive Cancer Network, the American Cancer Society, [or] the American Society of Clinical Oncology or the American Urological Association.
43	43
44	44
45	45
46	46
47	47	This act shall take effect as follows and shall amend the following sections:
48	48	Section 1 January 1, 2013 38a-492g
49	49	Sec. 2 January 1, 2013 38a-518g
50	50
51	51	This act shall take effect as follows and shall amend the following sections:
52	52
53	53	Section 1
54	54
55	55	January 1, 2013
56	56
57	57	38a-492g
58	58
59	59	Sec. 2
60	60
61	61	January 1, 2013
62	62
63	63	38a-518g
64	64
65	65	Statement of Purpose:
66	66
67	67	To add the American Urological Association to the list of organizations whose guidelines may be used in health insurance coverage for the treatment of prostate cancer.
68	68
69	69	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]